Contraindicated. Coadministration of doravirine with a robust CYP3A inducer might lower doravirine plasma concentrations and/or effects. Potential for loss of virologic reaction and feasible resistance to doravirine.The use of barbiturates as sedatives within the postoperative surgical period of time and as adjuncts to most cancers chemotherapy is